共 56 条
[1]
Molina AM(2011)Clinical practice guidelines for the treatment of metastatic renal cell carcinoma: today and tomorrow Oncologist 16 45-50
[2]
Motzer RJ(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-49
[3]
Sung H(2014)Immune checkpoint inhibitor-based therapy for advanced clear cell renal cell carcinoma: a narrative review Ren cell Carcinoma Bmj 349 g4797-64
[4]
Jonasch E(2022)Resistance to systemic therapies in Clear Cell Renal Cell Carcinoma: mechanisms and management strategies Int Immunopharmacol 110 108900-26
[5]
Gao J(2018)Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins Mol Cancer Ther 17 1355-8
[6]
Rathmell WK(2006)Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 Arch Biochem Biophys 449 17-20
[7]
Liu YF(2001)Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma Oncogene 20 980-8
[8]
Makhov P(1991)Common region of deletion on the long arm of chromosome 6 in non-hodgkin’s lymphoma and acute lymphoblastic leukaemia Cancer Res 51 5817-85
[9]
Campomenosi P(1994)A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer Genes Chromosomes Cancer 10 286-74
[10]
Acquati F(1996)Expression, location, clinical implication, and Bioinformatics Analysis of RNASET2 in gastric adenocarcinoma Oncogene 13 677-9